Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation

Published:2019-02 Issue: Volume:443 Page:80-90
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Cheng Honglin,Li Xin,Wang Chuanlin,Chen Yujie,Li Sijiang,Tan Jincai,Tan Bing,He Yunfeng

Funder

Chongqing Municipal Education Commission

Chongqing Municipal Science and Technology Commission

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2014

2. Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy;Yang;ACS Nano,2012

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N. Engl. J. Med.,2004

4. Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling;Zhu;Clin. Transl. Oncol.,2016

5. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells;Liu;Cell. Signal.,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of PARP1/2 and the tankyrases: emerging parallels;Biochemical Journal;2024-08-23

2. Study of the mechanism by which Xiaoyan decoction combined with E7449 regulates tumorigenesis in lung adenocarcinoma;Journal of Cellular and Molecular Medicine;2024-06

3. π-Stacking Interactions Involved in Gynecologic Tankyrase-1/Inhibitor Recognition and Association: Implications for Rational Design of Aromatic Pentapeptide Ligands;International Journal of Peptide Research and Therapeutics;2024-03-10

4. USP54 is a potential therapeutic target in castration-resistant prostate cancer;BMC Urology;2024-02-06

5. A novel TNKS/USP25 inhibitor blocks the Wnt pathway to overcome multi-drug resistance in TNKS-overexpressing colorectal cancer;Acta Pharmaceutica Sinica B;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3